ChemDiv, a global provider of integrated drug discovery solutions, today announced the extension of its Chemistry, Manufacturing and Controls (CMC) services collaboration supporting the clinical ...

If approved, it would be the first major new drug treatment for Parkinson’s in half a century. Richard Mailman, a University ...

Melanoma is the most common form of skin cancer, but for patients with advanced melanoma who no longer respond to standard ...

In combination, two commonly used heart drugs reverse fat accumulation in the liver, a study in animals has shown.

NMRA-898 is structurally distinct from NMRA-861 and is the second M4 PAM in Neumora’s M4 franchise; both programs have potential best-in-class ...

NMRA-215 demonstrated class-leading weight loss of up to 19% as a monotherapy with semaglutide-like induction NMRA-215 demonstrated best-in-class ...

NMRA-898 is structurally distinct from NMRA-861 and is the second M4 PAM in Neumora's M4 franchise; both programs have potential best-in-class pharmacology No convulsions observed in pre-clinical stud ...

Medications that prevent HIV, shrink tumors and treat seizures were invented with government funding. At research ...

SOTIO Biotech, a clinical-stage biopharmaceutical company owned by PPF Group, today announced it will present new preclinical and translational data from multiple investigational programs at two scien ...

Deanna Kroetz was inducted into the National Academy of Medicine, recognized for her pharmacogenetics research and mentoring.

Clinical and Pharmacology Data Presented at ACR Convergence 2025In a Phase II trial, LEVI-04 demonstrated a significant, dose-dependent reduction in bone marrow lesions (BML) compared with placebo in ...